微刺激与传统卵巢刺激在IVF poor responders中的比较:系统综述与Meta分析
该系统综述与Meta分析仅纳入随机对照试验,比较微刺激(每日≤150 IU促性腺激素单用或联合口服药)与传统剂量(每日>150 IU)IVF在poor responders中的效果。共纳入14项RCT,微刺激组活产率、持续妊娠率及周期取消率与传统组无显著差异,但获卵数和胚胎数较少,促性腺激素用量及费用降低。
要点
- 微刺激组活产率与传统组无显著差异(4项RCT,n=1057,RR 0.91,CI 0.66-1.25,中等质量证据)。
- 微刺激组获卵数和胚胎数较少,但高质量胚胎数量及比例相似。
- 微刺激减少促性腺激素用量和费用,证据支持其作为poor responders的优选策略。
核心结论
- 汇总人群证据显示微刺激与传统IVF疗效相当,且样本量对活产有足够把握度,支持poor responders优先选择微刺激而非更昂贵的传统IVF。
研究设计与样本
- 系统综述与Meta分析,仅纳入随机对照试验(RCT),检索MEDLINE、Embase、Cochrane中央对照试验注册库和PreMEDLINE,并手工检索,时间从2002年至2019年1月31日,共纳入14项RCT。
主要发现
- 活产率:4项RCT,n=1057,RR 0.91,CI 0.66至1.25,中等质量证据。
- 持续妊娠率:6项RCT,n=1782,RR 1.01,CI 0.86至1.20,中高质量证据。
- 周期取消率:14项RCT,n=2746,RR 1.38,CI 0.99至1.92,低质量证据。
- 微刺激组获卵数和胚胎数较少,但高质量胚胎的数量和比例相似;促性腺激素用量和费用降低。
- 排除存在偏倚风险的小型研究后,或无论单用促性腺激素还是联合口服药,推断均不变。
关键数值与推荐
- 微刺激定义:每日促性腺激素≤150 IU,单用或联合口服药物;传统剂量定义:每日>150 IU。
- 偏倚风险(ROB)和质量证据(QOE)按Cochrane协作网评估。
临床怎么用
- 作者认为证据支持poor responders优先选择微刺激策略而非更昂贵的传统IVF。
局限性
- 临床异质性仍是限制因素,但增加了研究结果的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mild ovarian stimulation is a treatment option for poor responders in IVF treatment. Our updated review evaluated mild IVF solely from randomized controlled trials (RCTs) that used genuine low-dose gonadotrophin (≤150 IU daily) alone or in combination with oral medications, comparing it with conventional-dose (>150 IU/ daily) IVF for poor responders. Electronic searches on MEDLINE, Embase, The Cochrane Central Register of Controlled Trials and PreMEDLINE, and hand searches from 2002 up to 31 January 2019, identified 14 RCTs, which were compiled with the above inclusion criteria. The risk of bias (ROB) and quality of evidence (QOE) were assessed as per Cochrane Collaboration. Meta-analyses found no difference in live birth rate (four RCTs, n = 1057, RR 0.91, CI 0.66 to 1.25) (moderate QOE), ongoing pregnancy rate (six RCTs, n = 1782, RR 1.01, CI 0.86 to 1.20) (moderate-high QOE) and cycle cancellation rates (14 RCTs, n = 2746, RR 1.38, CI 0.99 to 1.92) (low QOE). Fewer oocytes and embryos were obtained from mild IVF; however, the number and proportion of high-grade embryos were similar. Mild IVF resulted in reduced gonadotrophin use and cost. The inference remained unchanged when smaller studies with ROB were excluded, or whether gonadotrophin alone or combination with oral medication was used. The evidence of equal efficacy from a pooled population, which was adequately powered for live birth, supported a mild IVF strategy for poor responders in preference to more expensive conventional IVF. Although clinical heterogeneity remained a limiting factor, it increased the generalizability of the findings.
引用
- Datta AK, Maheshwari A, Felix N, et al. Mild versus conventional ovarian stimulation for IVF in poor responders: a systematic review and meta-analysis. Reprod Biomed Online. 2020. PMID: 32546333. doi:10.1016/j.rbmo.2020.03.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。